+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Drug-Eluting Devices Market by Device Type (Balloons, Catheters, Coronary Stents), Application (Cardiology, Neurovascular, Peripheral Vascular), End User, Material, Distribution Channel - Global Forecast 2025-2030- Product Image
Non-Drug-Eluting Devices Market by Device Type (Balloons, Catheters, Coronary Stents), Application (Cardiology, Neurovascular, Peripheral Vascular), End User, Material, Distribution Channel - Global Forecast 2025-2030- Product Image
New

Non-Drug-Eluting Devices Market by Device Type (Balloons, Catheters, Coronary Stents), Application (Cardiology, Neurovascular, Peripheral Vascular), End User, Material, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137922
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The non-drug-eluting device sector has evolved into a cornerstone of modern interventional therapies, delivering reliable solutions for a spectrum of cardiovascular and vascular interventions. Over recent years, technological breakthroughs in materials science and engineering have expanded the functional capabilities of stents, balloons, catheters, and guidewires, enhancing procedural precision and patient safety. The increasing prevalence of minimally invasive techniques has further elevated the demand for these devices, underscoring their critical role in reducing hospital stays, minimizing procedural risk, and improving long-term clinical outcomes.

As healthcare providers worldwide strive to optimize cost-efficiency and clinical efficacy, non-drug-eluting devices have emerged as a preferred choice for a range of indications. Their simplicity, lower cost of manufacture, and established safety profiles position them as indispensable tools in interventional cardiology and peripheral vascular procedures. This introductory overview establishes the foundational context for understanding the current market dynamics, technological innovations, and evolving clinical guidelines that drive adoption and shape competitive strategies within the non-drug-eluting device landscape.

Emerging Technological Advancements and Evolving Regulatory Landscapes Propelling the Next Generation of Non-Drug-Eluting Devices Toward Value-Based Healthcare Integration

The landscape of non-drug-eluting devices is undergoing transformative shifts driven by convergence of digital health, personalized medicine, and advanced manufacturing techniques. Additive manufacturing is enabling the rapid prototyping of intricate device architectures and patient-specific geometries, while enhanced materials such as nitinol and cobalt chromium alloys are improving device durability and biocompatibility. Concurrently, the integration of sensor-enabled technologies and smart coatings is paving the way for real-time procedural feedback, optimizing deployment accuracy and reducing complication rates.

Regulatory bodies are also refining approval pathways to accommodate these innovations, prompting faster time-to-market and encouraging investment in research and development. At the same time, payers and healthcare systems are placing greater emphasis on value-based care models that reward demonstrable clinical benefits and cost-effectiveness. Consequently, manufacturers are prioritizing outcomes-driven clinical trials and facilitating cross-functional collaborations to align product development with evolving reimbursement frameworks. Together, these forces are reshaping the competitive environment and defining new benchmarks for technological excellence.

Strategic Supply Chain Realignments and Cost Management Approaches in Response to Escalating United States Tariffs Impacting Non-Drug-Eluting Device Production

The cumulative impact of United States tariffs implemented through 2025 has introduced significant challenges across the non-drug-eluting device supply chain. Increased duties on raw materials and imported components have elevated production costs for manufacturers reliant on global sourcing, prompting a strategic reassessment of procurement and manufacturing footprints. In response, some industry leaders have initiated onshore manufacturing expansions and partnered with domestic suppliers to mitigate exposure to further tariff escalations and logistical disruptions.

These adjustments have not only reshaped cost structures but have also influenced pricing negotiations with distributors and healthcare providers. As manufacturers absorb portions of tariff-induced costs to preserve competitiveness, margin pressures have intensified and driven operational efficiency initiatives. Moreover, the broader geopolitical environment continues to foster uncertainty, compelling organizations to develop agile supply chain models that can rapidly pivot to alternative sourcing arrangements. Ultimately, the tariff landscape underscores the importance of strategic resilience in sustaining long-term growth and market stability.

Nuanced Profiling of Device Types Applications Materials and Distribution Pathways Driving Heterogeneous Demand Patterns Among Non-Drug-Eluting Device Stakeholders

An in-depth analysis of device type segmentation reveals that balloons exhibit diverse performance characteristics-compliant variants adapt to vessel morphology, non-compliant options deliver high-pressure precision, and semi-compliant alternatives balance flexibility with controlled expansion. Catheters demonstrate a bifurcation between diagnostic models for lesion imaging and interventional designs that encompass guiding and microcatheter configurations, enabling targeted therapy delivery. Coronary stents are distinguished by balloon-expandable versions that offer precise deployment and self-expanding counterparts that conform to vessel walls under dynamic conditions. Guidewires range from hydrophilic coated options that enhance navigability through intricate vasculature to polymer-jacketed designs that optimize steerability, while standard wire constructions maintain a cost-effective presence. Peripheral stents mirror coronary counterparts in their reliance on both balloon-expandable and self-expanding architectures adapted to peripheral arterial applications.

Beyond device type, application segments such as cardiology, neurovascular, peripheral vascular, and urology highlight the multifaceted clinical roles these devices play in addressing occlusive disease and structural interventions. Varied end-user environments-including ambulatory surgical centers, hospitals, and specialty clinics-further shape procurement strategies and service delivery models. Material considerations span cobalt chromium and stainless steel substrates, along with nitinol and polymer compositions, each selected for specific mechanical and biocompatibility profiles. Finally, distribution modalities through direct sales channels, distributor networks, and emerging online platforms influence market access and customer engagement strategies, underscoring the importance of tailored go-to-market approaches.

Diverse Regional Market Dynamics Reflecting Infrastructure Maturity Reimbursement Variability and Growth Trajectories Across Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics in the Americas underscore a mature interventional therapeutics market bolstered by well-established healthcare infrastructure and reimbursement frameworks. North America leads in procedural volumes and leans heavily on cost-containment measures to optimize care pathways. Latin American markets display rapid adoption trajectories, driven by investments in cardiovascular care centers and increasing patient awareness of minimally invasive options.

In the Europe, Middle East & Africa region, heterogeneous regulatory environments and varying healthcare expenditure levels shape disparate market conditions. Western Europe demonstrates steady growth anchored by robust clinical trial ecosystems and supportive public health initiatives, while the Middle East is witnessing expansion through public-private partnerships that fund advanced cardiovascular centers. Africa’s market remains nascent, with emphasis on capacity building and addressing unmet clinical needs.

Asia-Pacific presents a spectrum of opportunities, from advanced economies in Japan and South Korea where tailored device designs address specific patient demographics, to emerging markets in Southeast Asia and India that are rapidly scaling procedural capabilities. Strong governmental initiatives aimed at expanding healthcare access coupled with rising rates of lifestyle-related cardiovascular diseases contribute to sustained demand in the region.

Strategic Collaborations Clinical Evidence Generation and Niche Specialization Fueling Competitive Differentiation Among Key Non-Drug-Eluting Device Manufacturers

Leading medtech corporations have advanced portfolios of non-drug-eluting devices through targeted acquisitions and strategic alliances with specialized innovators. These collaborations have accelerated access to novel material compositions and proprietary manufacturing processes, reinforcing differentiation in a competitive market. At the same time, companies are investing in robust clinical evidence generation, leveraging real-world data registries and post-market surveillance to substantiate product performance and expand indications.

Mid-sized enterprises are carving out niches by focusing on specialized segments such as neurovascular interventions and peripheral artery disease, offering agile development cycles and customer-centric customization. Through digital platforms and surgeon training initiatives, these players are cultivating stronger customer relationships and driving device adoption. Meanwhile, distribution specialists are optimizing supply chain logistics and implementing data-driven demand forecasting to support just-in-time inventory models, reducing capital inefficiencies for healthcare providers.

Actionable Strategies for Building Supply Chain Resilience Enhancing Clinical Evidence and Accelerating Digital-Enabled Product Innovation for Sustainable Growth

Industry leaders should prioritize the establishment of diversified supply networks that blend local and international partners to reduce tariff and logistical risks. Embracing advanced analytics can enable real-time visibility across procurement, manufacturing, and distribution stages, facilitating proactive risk mitigation. Concurrently, forging collaborative alliances with clinical institutions to conduct outcome-based studies will strengthen the evidence base required for securing favorable reimbursement and payer alignment.

Organizations must also invest in digital integration initiatives that connect device performance data with hospital information systems, fostering continuous feedback loops for procedural optimization. Developing modular product platforms can accelerate customization for diverse patient anatomies and regional regulatory requirements, enhancing time-to-market agility. Finally, cultivating cross-functional teams comprising R&D, regulatory affairs, and commercial strategy experts will ensure cohesive execution of global expansion plans and responsive adaptation to evolving market conditions.

Robust Synthesis of Secondary Research Trade Data and Expert Interviews Underpinning Comprehensive Insights on Device Segments Supply Chains and Regional Trends

This study employs a rigorous multi-stage research methodology integrating both secondary and primary sources. Initially, extensive secondary research was conducted across peer-reviewed journals, regulatory filings, and industry whitepapers to map the technological landscape and identify key market drivers. This foundation was augmented by in-depth interviews with interventional cardiologists, vascular surgeons, and procurement managers to capture nuanced end-user perspectives and procedural workflows.

Quantitative data was triangulated through analysis of trade databases, customs statistics, and hospital procedural volumes to validate supply chain trends and tariff impacts. The qualitative insights were synthesized using thematic analysis techniques to ensure comprehensive coverage of regional nuances and segmentation dynamics. All findings underwent validation by industry experts and cross-verification with publicly disclosed financial and operational data to uphold accuracy and reliability.

Strategic Synthesis of Technological Innovation Regulatory Evolution and Market Segmentation Illuminating the Future Trajectory of Non-Drug-Eluting Therapeutic Devices

The non-drug-eluting device market stands at the intersection of technological innovation and evolving healthcare paradigms. Advances in materials science and smart device integration are redefining procedural precision and clinical outcomes, while regulatory refinements and value-based care models drive strategic realignments across the value chain. Segmentation analyses reveal that heterogeneous device types, applications, and distribution channels necessitate tailored approaches to meet diverse stakeholder needs.

Regionally, opportunities vary according to infrastructure maturity and healthcare investment priorities, requiring bespoke market entry strategies. Key industry players leverage collaborations and evidence generation to fortify competitive positioning, while emerging entrants find differentiation through niche specialization and digital engagement. As supply chain resilience and cost management become paramount, proactive diversification and data-driven decision-making will determine market leadership in the years ahead.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Balloons
      • Compliant
      • Non-Compliant
      • Semi-Compliant
    • Catheters
      • Diagnostic
      • Interventional
        • Guiding
        • Microcatheters
    • Coronary Stents
      • Balloon Expandable
      • Self Expanding
    • Guidewires
      • Hydrophilic Coated
      • Polymer Jacketed
      • Standard
    • Peripheral Stents
      • Balloon Expandable
      • Self Expanding
    • Sheaths
  • Application
    • Cardiology
    • Neurovascular
    • Peripheral Vascular
    • Urology
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Material
    • Cobalt Chromium
    • Nitinol
    • Polymer
    • Stainless Steel
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online Channels
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Cook Medical LLC
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Merit Medical Systems, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of bioresorbable vascular scaffolds offering temporary support and natural vessel healing
5.2. Integration of intravascular imaging modalities within non drug eluting devices for real time procedural guidance
5.3. Emergence of advanced polymer coatings enhancing hemocompatibility without reliance on drug elution technologies
5.4. Growing utility of patient specific 3d printed cardiovascular implants tailored to unique vessel anatomies
5.5. Advancements in robotic assisted delivery systems improving precision deployment of non drug eluting implants
5.6. Implementation of computational fluid dynamics driven design optimization to reduce restenosis in bare metal stents
5.7. Market growth driven by cost competitive generic bare metal stents in emerging healthcare systems
5.8. Regulatory focus on long term biocompatibility and manufacturing traceability for non drug eluting cardiovascular devices
5.9. Surge in demand for multifunctional catheter based platforms combining imaging sensors and diagnostic capabilities
5.10. Adoption of miniaturized guidewire integrated sensors enabling real time physiological feedback during interventions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-Drug-Eluting Devices Market, by Device Type
8.1. Introduction
8.2. Balloons
8.2.1. Compliant
8.2.2. Non-Compliant
8.2.3. Semi-Compliant
8.3. Catheters
8.3.1. Diagnostic
8.3.2. Interventional
8.3.2.1. Guiding
8.3.2.2. Microcatheters
8.4. Coronary Stents
8.4.1. Balloon Expandable
8.4.2. Self Expanding
8.5. Guidewires
8.5.1. Hydrophilic Coated
8.5.2. Polymer Jacketed
8.5.3. Standard
8.6. Peripheral Stents
8.6.1. Balloon Expandable
8.6.2. Self Expanding
8.7. Sheaths
9. Non-Drug-Eluting Devices Market, by Application
9.1. Introduction
9.2. Cardiology
9.3. Neurovascular
9.4. Peripheral Vascular
9.5. Urology
10. Non-Drug-Eluting Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Non-Drug-Eluting Devices Market, by Material
11.1. Introduction
11.2. Cobalt Chromium
11.3. Nitinol
11.4. Polymer
11.5. Stainless Steel
12. Non-Drug-Eluting Devices Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Channels
13. Americas Non-Drug-Eluting Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Non-Drug-Eluting Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Non-Drug-Eluting Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. Boston Scientific Corporation
16.3.3. Abbott Laboratories
16.3.4. Terumo Corporation
16.3.5. B. Braun Melsungen AG
16.3.6. BIOTRONIK SE & Co. KG
16.3.7. Cook Medical LLC
16.3.8. Becton, Dickinson and Company
16.3.9. Teleflex Incorporated
16.3.10. Merit Medical Systems, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NON-DRUG-ELUTING DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NON-DRUG-ELUTING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NON-DRUG-ELUTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NON-DRUG-ELUTING DEVICES MARKET: RESEARCHAI
FIGURE 26. NON-DRUG-ELUTING DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. NON-DRUG-ELUTING DEVICES MARKET: RESEARCHCONTACTS
FIGURE 28. NON-DRUG-ELUTING DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NON-DRUG-ELUTING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COMPLIANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COMPLIANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY NON-COMPLIANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY NON-COMPLIANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SEMI-COMPLIANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SEMI-COMPLIANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY POLYMER JACKETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY POLYMER JACKETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STANDARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SHEATHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SHEATHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NON-DRUG-ELUTING DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 150. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 151. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 152. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 153. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 154. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 155. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 156. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 157. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 158. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 159. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 160. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 161. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 166. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 167. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 188. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 189. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA NON-DRUG-ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 288. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 289. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 292. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 293. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 300. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. GERMANY NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 306. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 307. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 308. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 309. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 310. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 311. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
TABLE 312. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY CORONARY STENTS, 2025-2030 (USD MILLION)
TABLE 313. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2024 (USD MILLION)
TABLE 314. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY GUIDEWIRES, 2025-2030 (USD MILLION)
TABLE 315. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY PERIPHERAL STENTS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 322. FRANCE NON-DRUG-ELUTING DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 323. FRANCE NON

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-Drug-Eluting Devices market report include:
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Cook Medical LLC
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Merit Medical Systems, Inc.

Related Topics

Related Reports

Drug Eluting Balloon Market by Application (Coronary Artery Disease, Peripheral Artery Disease), Drug Type (Paclitaxel-Coated, Sirolimus-Coated), End User, Product Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Drug Eluting Balloon Market by Application (Coronary Artery Disease, Peripheral Artery Disease), Drug Type (Paclitaxel-Coated, Sirolimus-Coated), End User, Product Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Implantable Drug Eluting Balloon Market by Indication (De Novo Lesion, in-Stent Restenosis), Product Type (Coronary, Peripheral), Drug Type, End User - Global Forecast 2025-2030 - Product Image

Implantable Drug Eluting Balloon Market by Indication (De Novo Lesion, in-Stent Restenosis), Product Type (Coronary, Peripheral), Drug Type, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Implantable Coronary Drug Eluting Stent Market by Drug Type (Everolimus Eluting, Paclitaxel Eluting, Sirolimus Eluting), Generation (First Generation, Second Generation, Third Generation), Polymer Type, Stent Material, Indication - Global Forecast 2025-2030 - Product Image

Implantable Coronary Drug Eluting Stent Market by Drug Type (Everolimus Eluting, Paclitaxel Eluting, Sirolimus Eluting), Generation (First Generation, Second Generation, Third Generation), Polymer Type, Stent Material, Indication - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Drug Eluting Guidewire Market by Material (Nitinol, Polymer Coated, Stainless Steel), Application (Cardiovascular, Neurovascular, Peripheral), Coating, Tip Configuration, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Drug Eluting Guidewire Market by Material (Nitinol, Polymer Coated, Stainless Steel), Application (Cardiovascular, Neurovascular, Peripheral), Coating, Tip Configuration, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.